CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The IMPORTANT project aims to evaluate the effectiveness of CDK 4/6-inhibitors combined with endocrine therapy in older patients with advanced breast cancer. It will conduct a pragmatic clinical study across six European countries, focusing on personalized treatment strategies and real-world applicability to improve cl…
Current evidence from both randomized trials and real-world evidence studies suggests that older breast cancer patients derive clinical benefit from the addition of CDK 4/6-inhibitors to endocrine therapy but with higher risk for adverse events and treatment discontinuation compared to younger patients.
The IMPORTANT project will design and conduct a pragmatic clinical study with a decentralised approach for older patients with advanced breast cancer aiming at high level of evidence (level I) wi…
OREBRO LANS LANDSTING
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Orebro
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Rio Patras
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Florence
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
